Gibson, Dunn & Crutcher advised Intel, while Davis Polk & Wardwell advised the underwriters on the offering. Intel Corporation executed the offering consisting of $1.25 billion aggregate principal...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell, Mayer Brown, and Mishcon de Reya advised Gilead, while Goodwin Procter and Wilson Sonsini Goodrich & Rosati advised MiroBio on the deal....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering while Jones Day advised GenScript Biotech Corporation. Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering. Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Precigen on the deal. Precigen, Inc. executed the sale of its wholly-owned non-healthcare subsidiary, Trans Ova Genetics, L.C. (“Trans Ova”), an industry-leading animal...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriter, SVB Securities, in the offering. Applied Therapeutics, Inc. announced its offering of 20,000,000 shares of common stock, pre-funded warrants to purchase up...
You must be a Standard 1 Year member to access this content.
Davis Polk advised GSK plc on the deal while Gunderson Dettmer represented Affinivax. GSK plc announced its acquisition of Affinivax, Inc. for a $2.1 billion upfront...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom advised PayPal, while Davis Polk advised the joint book-running managers and representatives of the underwriters and the dealer manager in...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Bausch Health Companies Inc. in connection with the separation of its eye health business into a new publicly traded company, Bausch + Lomb...
You must be a Standard 1 Year member to access this content.
Cravath represented Qualcomm, while Davis Polk advised the representatives of the several underwriters in the offering. Qualcomm Incorporated executed its offering of $500 million aggregate principal...
You must be a Standard 1 Year member to access this content.
Cooley advised SiTime Corporation, while Davis Polk advised the sales agent, Stifel, Nicolaus & Company, in the offering. SiTime Corporation issued an SEC-registered at-the-market offering consisting of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers, J.P. Morgan Securities LLC and Jefferie, in the offering. Deciphera Pharmaceuticals, Inc. executed a $172.5 million SEC-registered common stock and...
You must be a Standard 1 Year member to access this content.
